Plasma dopamine: regulation and significance.

Area of Science:

• Neuroendocrinology
• Biochemistry
• Physiology

Background:

• Dopamine (DA) is present in plasma, mainly as sulfate or glucuronide conjugates.
• The origin and precise physiological role of circulating DA remain incompletely understood.
• Plasma DA concentrations are lower than epinephrine (E) and norepinephrine (NE), with free DA constituting less than 2% of total plasma DA.

Purpose of the Study:

• To investigate the physiological and pathophysiological roles of dopamine (DA) in human plasma.
• To understand the factors influencing plasma DA concentrations and their relationship to sympathetic tone and hormonal regulation.

Main Methods:

• Measurement of plasma dopamine (DA) and its metabolites under various physiological and pharmacological conditions.
• Analysis of plasma DA responses to sympathetic stimulation, dietary changes, and drug administration (L-DOPA, carbidopa, bromocriptine, haloperidol, beta-endorphin).

Main Results:

• Plasma free DA concentrations increase with sympathetic activation (e.g., upright posture, exercise, stress, hypoglycemia) but to a lesser extent than NE or E.
• Plasma DA decreases during sodium depletion, aligning with a role in aldosterone regulation.
• Administration of DA precursors or antagonists influences plasma DA levels, while agonists may decrease them.
• Central beta-endorphin administration increases plasma DA, indicating a link to central sympathetic outflow.

Conclusions:

• Circulating dopamine exhibits dynamic changes in response to physiological stimuli and pharmacological interventions.
• Evidence suggests a role for plasma DA in sympathetic regulation and potentially in aldosterone secretion.
• Further research is required to elucidate the complete physiological significance and clinical implications of plasma DA.